Drug Shortage Report for MYLAN-CLOPIDOGREL
| Report ID | 30326 |
| Drug Identification Number | 02351536 |
| Brand name | MYLAN-CLOPIDOGREL |
| Common or Proper name | MYLAN-CLOPIDOGREL |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | CLOPIDOGREL |
| Strength(s) | 75MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100BT, 500BT |
| ATC code | B01AC |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2018-03-01 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | 2018-03-01 |
| Shortage status | Resolved |
| Updated date | 2018-05-02 |
| Company comments | discontinued in ID 30319 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2018-05-02 | English | Compare |
| v5 | 2018-03-02 | English | Compare |
| v4 | 2018-03-01 | French | Compare |
| v3 | 2018-03-01 | English | Compare |
| v2 | 2017-11-23 | French | Compare |
| v1 | 2017-11-23 | English | Compare |
Showing 1 to 6 of 6